Correlation Between Catalent and Dr Reddys

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Catalent and Dr Reddys at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Catalent and Dr Reddys into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Catalent and Dr Reddys Laboratories, you can compare the effects of market volatilities on Catalent and Dr Reddys and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Catalent with a short position of Dr Reddys. Check out your portfolio center. Please also check ongoing floating volatility patterns of Catalent and Dr Reddys.

Diversification Opportunities for Catalent and Dr Reddys

-0.35
  Correlation Coefficient

Very good diversification

The 3 months correlation between Catalent and RDDA is -0.35. Overlapping area represents the amount of risk that can be diversified away by holding Catalent and Dr Reddys Laboratories in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Dr Reddys Laboratories and Catalent is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Catalent are associated (or correlated) with Dr Reddys. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Dr Reddys Laboratories has no effect on the direction of Catalent i.e., Catalent and Dr Reddys go up and down completely randomly.

Pair Corralation between Catalent and Dr Reddys

Assuming the 90 days horizon Catalent is expected to generate 0.64 times more return on investment than Dr Reddys. However, Catalent is 1.56 times less risky than Dr Reddys. It trades about 0.41 of its potential returns per unit of risk. Dr Reddys Laboratories is currently generating about 0.24 per unit of risk. If you would invest  5,548  in Catalent on September 22, 2024 and sell it today you would earn a total of  445.00  from holding Catalent or generate 8.02% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthInsignificant
Accuracy95.45%
ValuesDaily Returns

Catalent  vs.  Dr Reddys Laboratories

 Performance 
       Timeline  
Catalent 

Risk-Adjusted Performance

17 of 100

 
Weak
 
Strong
Solid
Compared to the overall equity markets, risk-adjusted returns on investments in Catalent are ranked lower than 17 (%) of all global equities and portfolios over the last 90 days. Despite nearly fragile basic indicators, Catalent may actually be approaching a critical reversion point that can send shares even higher in January 2025.
Dr Reddys Laboratories 

Risk-Adjusted Performance

2 of 100

 
Weak
 
Strong
Weak
Compared to the overall equity markets, risk-adjusted returns on investments in Dr Reddys Laboratories are ranked lower than 2 (%) of all global equities and portfolios over the last 90 days. Despite nearly stable fundamental indicators, Dr Reddys is not utilizing all of its potentials. The current stock price disturbance, may contribute to mid-run losses for the stockholders.

Catalent and Dr Reddys Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Catalent and Dr Reddys

The main advantage of trading using opposite Catalent and Dr Reddys positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Catalent position performs unexpectedly, Dr Reddys can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Dr Reddys will offset losses from the drop in Dr Reddys' long position.
The idea behind Catalent and Dr Reddys Laboratories pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Positions Ratings module to determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance.

Other Complementary Tools

Idea Analyzer
Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas
Portfolio Backtesting
Avoid under-diversification and over-optimization by backtesting your portfolios
Bond Analysis
Evaluate and analyze corporate bonds as a potential investment for your portfolios.
Transaction History
View history of all your transactions and understand their impact on performance
Price Exposure Probability
Analyze equity upside and downside potential for a given time horizon across multiple markets